Renal Failure in Patients with Cirrhosis

Medical Clinics of North America

Volumn 93, Issue 4, 2009, Pages 855-869

  Mackelaite, Lina ^a   Alsauskas, Zygimantas C ^b   Ranganna, Karthik ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cirrhosis; Glomerular disease; Hepatitis B virus; Hepatitis C virus; Hepatorenal syndrome; Renal failure

Indexed keywords

ALBUMIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; CEFOTAXIME; CONTRAST MEDIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; GENTAMICIN; LAMIVUDINE; MIDODRINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; NORFLOXACIN; OCTREOTIDE; PLACEBO; SPIRONOLACTONE; TERLIPRESSIN; TOBRAMYCIN;

ABDOMINAL COMPARTMENT SYNDROME; ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ASCITES; BACTERIAL PERITONITIS; CLINICAL TRIAL; CREATININE CLEARANCE; DISEASE CLASSIFICATION; DIURESIS; DRUG WITHDRAWAL; EDEMA; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HEPATITIS B; HEPATITIS C; HEPATORENAL SYNDROME; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FAILURE; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DAMAGE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PARACENTESIS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; REVIEW; SIDE EFFECT; SODIUM EXCRETION; SODIUM RETENTION;

COMPARTMENT SYNDROMES; CREATININE; DIURETICS; GLOMERULONEPHRITIS, IGA; HEPATITIS B; HEPATITIS C; HEPATORENAL SYNDROME; HUMANS; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; LIVER CIRRHOSIS; PARACENTESIS; PROGNOSIS;

EID: 67649408821     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2009.03.003     Document Type: Review

References (86)

1. Stevens L.A., and Levey A.S. Measurement of kidney function. Med Clin North Am 89 3 (2005) 457-473
2. Cocchetto D.M., Tschanz C., and Bjornsson T.D. Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance. Ther Drug Monit 5 2 (1983) 161-168
3. Sherman D.S., Fish D.N., and Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis 41 2 (2003) 269-278
4. Roy L., Legault L., and Pomier-Layrargues G. Glomerular filtration rate measurement in cirrhotic patients with renal failure. Clin Nephrol 50 6 (1998) 342-346
5. Papadakis M.A., and Arieff A.I. Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study. Am J Med 82 5 (1987) 945-952
6. Gonwa T.A., Jennings L., Mai M.L., et al. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 10 2 (2004) 301-309
7. Orlando R., Mussap M., Plebani M., et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 48 6 Pt 1 (2002) 850-858
8. Poge U., Gerhardt T., Stoffel-Wagner B., et al. Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant 21 3 (2006) 660-664
9. Cholongitas E., Marelli L., Kerry A., et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 13 4 (2007) 523-529
10. Daugherty N.A., Hammond K.B., and Osberg I.M. Bilirubin interference with the kinetic Jaffe method for serum creatinine. Clin Chem 24 2 (1978) 392-393
11. Malinchoc M., Kamath P.S., Gordon F.D., et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31 4 (2000) 864-871
12. Wiesner R., Edwards E., Freeman R., et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124 1 (2003) 91-96
13. United Network for Organ Sharing. Resources: MELD/PELD calculator. Available at:. http://www.unos.org/resources/MeldPeldCalculator.asp?index=98 Accessed November 17, 2008
14. Alessandria C., Ozdogan O., Guevara M., et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 41 6 (2005) 1282-1289
15. Nair S., Verma S., and Thuluvath P.J. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 35 5 (2002) 1179-1185
16. Martin P.Y., Gines P., and Schrier R.W. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 339 8 (1998) 533-541
17. Schrier R.W., Arroyo V., Bernardi M., et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8 5 (1988) 1151-1157
18. Arroyo V., Bosch J., Gaya-Beltran J., et al. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Intern Med 94 2 (1981) 198-201
19. Bichet D.G., Van Putten V.J., and Schrier R.W. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med 307 25 (1982) 1552-1557
20. Bichet D., Szatalowicz V., Chaimovitz C., et al. Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann Intern Med 96 4 (1982) 413-417
21. Pockros P.J., and Reynolds T.B. Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema. Gastroenterology 90 6 (1986) 1827-1833
22. Arroyo V., Gines P., Gerbes A.L., et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 23 1 (1996) 164-176
23. Gines P., Tito L., Arroyo V., et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 94 6 (1988) 1493-1502
24. Runyon B.A. Management of adult patients with ascites due to cirrhosis. Hepatology 39 3 (2004) 841-856
25. Gines A., Escorsell A., Gines P., et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 105 1 (1993) 229-236
26. Fernandez-Seara J., Prieto J., Quiroga J., et al. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology 97 5 (1989) 1304-1312
27. Ruiz-del-Arbol L., Monescillo A., Arocena C., et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 42 2 (2005) 439-447
28. Follo A., Llovet J.M., Navasa M., et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 20 6 (1994) 1495-1501
29. Salerno F., Gerbes A., Gines P., et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56 9 (2007) 1310-1318
30. Sort P., Navasa M., Arroyo V., et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341 6 (1999) 403-409
31. Fernandez J., Navasa M., Planas R., et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133 3 (2007) 818-824
32. Angeli P., Volpin R., Gerunda G., et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 29 6 (1999) 1690-1697
33. Martin-Llahi M., Pepin M.N., Guevara M., et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 134 5 (2008) 1352-1359
34. Sanyal A.J., Boyer T., Garcia-Tsao G., et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 134 5 (2008) 1360-1368
35. Duvoux C., Zanditenas D., Hezode C., et al. Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology 36 2 (2002) 374-380
36. Munoz S.J. The hepatorenal syndrome. Med Clin North Am 92 4 (2008) 813-837 viii-ix
37. Lim J.K., and Groszmann R.J. Vasoconstrictor therapy for the hepatorenal syndrome. Gastroenterology 134 5 (2008) 1608-1611
38. Gonwa T.A., Morris C.A., Goldstein R.M., et al. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome-experience in 300 patients. Transplantation 51 2 (1991) 428-430
39. de Cleva R., Silva F.P., Zilberstein B., et al. Acute renal failure due to abdominal compartment syndrome: report on four cases and literature review. Rev Hosp Clin Fac Med Sao Paulo 56 4 (2001) 123-130
40. Cheatham M.L., Malbrain M.L., Kirkpatrick A., et al. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations. Intensive Care Med 33 6 (2007) 951-962
41. Richards W.O., Scovill W., Shin B., et al. Acute renal failure associated with increased intra-abdominal pressure. Ann Surg 197 2 (1983) 183-187
42. Doty J.M., Saggi B.H., Blocher C.R., et al. Effects of increased renal parenchymal pressure on renal function. J Trauma 48 5 (2000) 874-877
43. Sugrue M., Bauman A., Jones F., et al. Clinical examination is an inaccurate predictor of intraabdominal pressure. World J Surg 26 12 (2002) 1428-1431
44. Sinniah R. Heterogeneous IgA glomerulonephropathy in liver cirrhosis. Histopathology 8 6 (1984) 947-962
45. McGuire B.M., Julian B.A., Bynon J.S.J., et al. Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med 144 10 (2006) 735-741
46. Sancho J., Egido J., Sanchez-Crespo M., et al. Detection of monomeric and polymeric IgA containing immune complexes in serum and kidney from patients with alcoholic liver disease. Clin Exp Immunol 47 2 (1982) 327-335
47. Coppo R., Arico S., Piccoli G., et al. Presence and origin of IgA1- and IgA2-containing circulating immune complexes in chronic alcoholic liver diseases with and without glomerulonephritis. Clin Immunol Immunopathol 35 1 (1985) 1-8
48. Giron J.A., Alvarez-Mon M., Menendez-Caro J.L., et al. Increased spontaneous and lymphokine-conditioned IgA and IgG synthesis by B cells from alcoholic cirrhotic patients. Hepatology 16 3 (1992) 664-670
49. Delacroix D.L., Elkom K.B., Geubel A.P., et al. Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A. J Clin Invest 71 2 (1983) 358-367
50. Rifai A., Fadden K., Morrison S.L., et al. The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes. J Exp Med 191 12 (2000) 2171-2182
51. Lomax-Smith J.D., Zabrowarny L.A., Howarth G.S., et al. The immunochemical characterization of mesangial IgA deposits. Am J Pathol 113 3 (1983) 359-364
52. Kalambokis G., Christou L., Stefanou D., et al. Association of liver cirrhosis related IgA nephropathy with portal hypertension. World J Gastroenterol 13 43 (2007) 5783-5786
53. Nakamura M., Ohishi A., Watanabe R., et al. IgA nephropathy associated with portal hypertension in liver cirrhosis due to non-alcoholic and non-A, non-B, non-C hepatitis. Intern Med 33 8 (1994) 488-491
54. Arase Y., Ikeda K., Murashima N., et al. Glomerulonephritis in autopsy cases with hepatitis C virus infection. Intern Med 37 10 (1998) 836-840
55. Johnson R.J., Willson R., Yamabe H., et al. Renal manifestations of hepatitis C virus infection. Kidney Int 46 5 (1994) 1255-1263
56. Agnello V., Chung R.T., and Kaplan L.M. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327 21 (1992) 1490-1495
57. Uchiyama-Tanaka Y., Mori Y., Kishimoto N., et al. Membranous glomerulonephritis associated with hepatitis C virus infection: case report and literature review. Clin Nephrol 61 2 (2004) 144-150
58. Stehman-Breen C., Alpers C.E., Couser W.G., et al. Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol 44 3 (1995) 141-147
59. Altraif I.H., Abdulla A.S., al Sebayel M.I., et al. Hepatitis C associated glomerulonephritis. Am J Nephrol 15 5 (1995) 407-410
60. Sansonno D., Gesualdo L., Manno C., et al. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 25 5 (1997) 1237-1244
61. Misiani R., Bellavita P., Fenili D., et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330 11 (1994) 751-756
62. Johnson R.J., Gretch D.R., Couser W.G., et al. Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int 46 6 (1994) 1700-1704
63. Alric L., Plaisier E., Thebault S., et al. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis 43 4 (2004) 617-623
64. Reau N., Hadziyannis S.J., Messinger D., et al. Early predictors of anemia in patients with hepatitis C genotype 1 treated with peginterferon alfa-2a (40KD) plus ribavirin. Am J Gastroenterol 103 8 (2008) 1981-1988
65. Roccatello D., Baldovino S., Rossi D., et al. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant 19 12 (2004) 3054-3061
66. Levy M., and Chen N. Worldwide perspective of hepatitis B-associated glomerulonephritis in the 80s. Kidney Int Suppl 35 (1991) S24-S33
67. Lai K.N., Li P.K., Lui S.F., et al. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 324 21 (1991) 1457-1463
68. Takekoshi Y., Tochimaru H., Nagata Y., et al. Immunopathogenetic mechanisms of hepatitis B virus-related glomerulopathy. Kidney Int Suppl 35 (1991) S34-S39
69. Conjeevaram H.S., Hoofnagle J.H., Austin H.A., et al. Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology 109 2 (1995) 540-546
70. Tang S., Lai F.M., Lui Y.H., et al. Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int 68 4 (2005) 1750-1758
71. Dudley F.J., Kanel G.C., Wood L.J., et al. Hepatorenal syndrome without avid sodium retention. Hepatology 6 2 (1986) 248-251
72. Edmondson H.A., Reynolds T.B., and Jacobson H.G. Renal papillary necrosis with special reference to chronic alcoholism. A report of 20 cases. Arch Intern Med 118 3 (1966) 255-264
73. Longacre A.M., and Popky G.L. Papillary necrosis in patients with cirrhosis: a study of 102 patients. J Urol 99 4 (1968) 391-395
74. Lopez-Parra M., Claria J., Planaguma A., et al. Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites. Br J Pharmacol 135 4 (2002) 891-900
75. Hsia H.C., Lin H.C., Tsai Y.T., et al. The effects of chronic administration of indomethacin and misoprostol on renal function in cirrhotic patients with and without ascites. Scand J Gastroenterol 30 12 (1995) 1194-1199
76. Brater D.C., Anderson S.A., Brown-Cartwright D., et al. Effects of nonsteroidal antiinflammatory drugs on renal function in patients with renal insufficiency and in cirrhotics. Am J Kidney Dis 8 5 (1986) 351-355
77. Runyon B.A. Refractory ascites. Semin Liver Dis 13 4 (1993) 343-351
78. Henriksen J.H., and Moller S. Liver cirrhosis and arterial hypertension. World J Gastroenterol 12 5 (2006) 678-685
79. Moore R.D., Smith C.R., Lipsky J.J., et al. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 100 3 (1984) 352-357
80. Hampel H., Bynum G.D., Zamora E., et al. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol 96 7 (2001) 2206-2210
81. Howard C.S., and Teitelbaum I. Renal replacement therapy in patients with chronic liver disease. Semin Dial 18 3 (2005) 212-216
82. Wilkinson S.P., Weston M.J., Parsons V., et al. Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol 8 1 (1977) 287-292
83. Wong L.P., Blackley M.P., Andreoni K.A., et al. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int 68 1 (2005) 362-370
84. Marcus R.G., Messana J., and Swartz R. Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites. Am J Med 93 1 (1992) 35-40
85. De Vecchi A.F., Colucci P., Salerno F., et al. Outcome of peritoneal dialysis in cirrhotic patients with chronic renal failure. Am J Kidney Dis 40 1 (2002) 161-168
86. Eason J.D., Gonwa T.A., Davis C.L., et al. Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK). Am J Transplant 8 11 (2008) 2243-2251